(Q40648405)

English

Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells

scientific article published on May 12, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Transforming growth factor-beta1 produced by ovarian cancer cell line HRA stimulates attachment and invasion through an up-regulation of plasminogen activator inhibitor type-1 in human peritoneal mesothelial cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Transforming Growth Factor-β1 Produced by Ovarian Cancer Cell Line HRA Stimulates Attachment and Invasion through an Up-regulation of Plasminogen Activator Inhibitor Type-1 in Human Peritoneal Mesothelial Cells (English)

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

1 reference

based on heuristic

inferred from title

cancer cell line

1 reference

based on heuristic

inferred from title

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Hiroshi Kobayashi

2

object named as

Hiroshi Kobayashi

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

author name string

Yasuyuki Hirashima

1

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Mika Suzuki

3

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Yoshiko Tanaka

4

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Naohiro Kanayama

5

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Toshihiko Terao

6

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

language of work or name

0 references

publication date

12 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

full work available at URL

http://www.jbc.org/article/S0021925820846377/pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12743121

1 January 2024

https://api.elsevier.com/content/article/PII:S0021925820846377?httpAccept=text/xml

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

https://api.elsevier.com/content/article/PII:S0021925820846377?httpAccept=text/plain

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

https://syndication.highwire.org/content/doi/10.1074/jbc.M212187200

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

278

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

26793-26802

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Anti-metastatic therapy by urinary trypsin inhibitor in combination with an anti-cancer agent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Suppression of urokinase expression and invasiveness by urinary trypsin inhibitor is mediated through inhibition of protein kinase C- and MEK/ERK/c-Jun-dependent signaling pathways

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Characterization of binding properties of urinary trypsin inhibitor to cell-associated binding sites on human chondrosarcoma cell line HCS-2/8.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Suppression of invasion and peritoneal carcinomatosis of ovarian cancer cell line by overexpression of bikunin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

PAI-1 secretion and matrix deposition in human peritoneal mesothelial cell cultures: transcriptional regulation by TGF-beta 1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Efficientin vitrosynthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

A Kunitz-type protease inhibitor, bikunin, inhibits ovarian cancer cell invasion by blocking the calcium-dependent transforming growth factor-beta 1 signaling cascade

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Cytokines induce urokinase-dependent adhesion of human myeloid cells. A regulatory role for plasminogen activator inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Human endothelial cell migration is stimulated by urokinase plasminogen activator:plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor beta1; possible mechanism for paracrine st

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Enhanced expression of the urokinase-type plasminogen activator gene and reduced colony formation in soft agar by ectopic expression of PU.1 in HT1080 human fibrosarcoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Clinical utility of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 determination in primary breast cancer tissue for individualized therapy concepts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Proteolytic balance and capillary morphogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Dipyridamole inhibits TGF-beta-induced collagen gene expression in human peritoneal mesothelial cells.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M212187200

21 January 2018

Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen

6

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer

7

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta

8

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

10

27

41

author name string

Massague

publication date

1996

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Cancer Research

11

57

628

author name string

Frey

publication date

1997

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Differential regulation of mesothelial cell fibrinolysis by transforming growth factor beta 1

15

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Cancer Research

16

47

592

author name string

Kikuchi

publication date

1987

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Isolation, culture and characterization of human peritoneal mesothelial cells

18

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Phenotypic differences in cytokine responsiveness of hypertrophic scar versus normal dermal fibroblasts

19

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Identification and characterization of the cell-associated binding protein for urinary trypsin inhibitor

21

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells

25

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Effect of inflammatory cytokines and growth factors on tumour cell adhesion to the peritoneum

26

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Potentiation by thyroxine of interferon-gamma-induced antiviral state requires PKA and PKC activities

28

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Induction of c-fos gene expression by urokinase-type plasminogen activator in human ovarian cancer cells

30

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer

37

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Co-expression of urokinase, urokinase receptor and PAI-1 is necessary for optimum invasiveness of cultured lung cancer cells

41

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Adhesion molecules and TGF-beta1 are involved in the peritoneal dissemination of NUGC-4 human gastric cancer cells

44

1 reference

10.1074/JBC.M212187200

https://api.crossref.org/works/10.1074/JBC.M212187200

1 January 2024

Identifiers

10.1074/JBC.M212187200

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40648405&oldid=2042571959"